<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre=": courier ; font-style : italic;} Mol TherMol. TherMolecular Therapy1525-00161525-0024The" exact="American" post="Society of Gene and Cell Therapy. pmcid: 6904818S1525-0016(19)30458-7 doi:"/>
 <result pre="Shi, Department of Biochemistry and Molecular Biology, Sealy Center for" exact="Structural" post="Biology and Molecular Biophysics, Sealy Institute for Vaccine Sciences,"/>
 <result pre="Texas TX 77555, USA. peshi@utmb.edu pmc-release: 2019-10-10ppub: 2019-12-12epub: 2019-10-10271220642066(C) The" exact="American" post="Society of Gene and Cell Therapy, 2019Since January 2020"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="virus (ZIKV) is a mosquito-borne flavivirus that can cause devastating" exact="microcephaly" post="and other congenital syndromes in infants born to infected"/>
 <result pre="a mosquito-borne flavivirus that can cause devastating microcephaly and other" exact="congenital" post="syndromes in infants born to infected pregnant women as"/>
 <result pre="infants born to infected pregnant women as well as Guillain-BarrÃ©" exact="syndrome" post="in infected adults.1 In this issue of Molecular Therapy,"/>
 <result pre="clinically approved drugs for possible prevention and treatment of ZIKV" exact="infection" post="and its associated disease. Although emerging infectious diseases have"/>
 <result pre="treatment of ZIKV infection and its associated disease. Although emerging" exact="infectious diseases" post="have been recognized for many decades, the last 20"/>
 <result pre="the unprecedented emergence of several devastating epidemics of zoonotic RNA" exact="viral" post="diseases, such as severe acute respiratory syndrome (SARS), middle"/>
 <result pre="devastating epidemics of zoonotic RNA viral diseases, such as severe" exact="acute" post="respiratory syndrome (SARS), middle east respiratory syndrome (MERS), Ebola,"/>
 <result pre="epidemics of zoonotic RNA viral diseases, such as severe acute" exact="respiratory" post="syndrome (SARS), middle east respiratory syndrome (MERS), Ebola, Nipah,"/>
 <result pre="of zoonotic RNA viral diseases, such as severe acute respiratory" exact="syndrome" post="(SARS), middle east respiratory syndrome (MERS), Ebola, Nipah, chikungunya,"/>
 <result pre="diseases, such as severe acute respiratory syndrome (SARS), middle east" exact="respiratory" post="syndrome (MERS), Ebola, Nipah, chikungunya, West Nile, yellow fever,"/>
 <result pre="such as severe acute respiratory syndrome (SARS), middle east respiratory" exact="syndrome" post="(MERS), Ebola, Nipah, chikungunya, West Nile, yellow fever, and"/>
 <result pre="middle east respiratory syndrome (MERS), Ebola, Nipah, chikungunya, West Nile," exact="yellow fever," post="and ZIKV. Given the unpredictable nature of emerging pathogens,"/>
 <result pre="therapy is an important countermeasure to prevent, treat, and block" exact="viral" post="transmission.3 Because new drugs usually take more than 10"/>
 <result pre="in both cell cultures and mouse models by blocking the" exact="viral" post="RdRp (FigureÂ 1 ). FigureÂ 1 Rilpivirine Inhibits ZIKV"/>
 <result pre="(FigureÂ 1 ). FigureÂ 1 Rilpivirine Inhibits ZIKV by Blocking" exact="Viral" post="RdRp (A) Proposed rilpivirine binding site on ZIKV RdRp."/>
 <result pre="InÂ vivo efficacy. Treatment of ZIKV-infected mice with rilpivirine suppressed" exact="viral" post="replication and prevented animal death. First, Sariyer etÂ al.2"/>
 <result pre="prevented animal death. First, Sariyer etÂ al.2 found that human" exact="primary" post="astrocytes are more susceptible to ZIKV infection than several"/>
 <result pre="found that human primary astrocytes are more susceptible to ZIKV" exact="infection" post="than several other human cell types, including fetal microglia,"/>
 <result pre="fetal microglia, fetal neuron, and neural progenitor cells. Using ZIKV" exact="infection" post="of astrocytes as a screening assay, they identified rilpivirine"/>
 <result pre="higher susceptibility of astrocytes than other cell types to ZIKV" exact="infection" post="is intriguing because previous studies suggested that ZIKV preferentially"/>
 <result pre="is essential to gauge potential adverse effect caused by non-specific" exact="infection" post="and killing of non-tumor cells. It remains to be"/>
 <result pre="if rilpivirine also inhibits closely related flaviviruses, such as dengue," exact="yellow fever," post="West Nile, and Japanese encephalitis viruses. Nevertheless, the authors"/>
 <result pre="related flaviviruses, such as dengue, yellow fever, West Nile, and" exact="Japanese encephalitis" post="viruses. Nevertheless, the authors have established the antiviral activity"/>
 <result pre="flaviviruses, such as dengue, yellow fever, West Nile, and Japanese" exact="encephalitis" post="viruses. Nevertheless, the authors have established the antiviral activity"/>
 <result pre="rilpivirine will identify mutations that are likely mapped to the" exact="viral" post="NS5 RdRp gene. Third, Sariyer etÂ al.2 demonstrated the"/>
 <result pre="1B). Treatment of ZIKV-infected IFNARâˆ’/âˆ’ mice with rilpivirine reduced organ" exact="viral" post="burden and weight loss, improved clinical score, and prevented"/>
 <result pre="clinical score, and prevented death. In the un-treated mouse brain," exact="viral" post="RNA was detected in astrocytes, microglia/macrophage, TÂ cells, and"/>
 <result pre="and neurons, but not neural progenitor cells.Â In addition, ZIKV" exact="infection" post="caused significant inflammation and abundant apoptotic/necrotic cell damage. Treatment"/>
 <result pre="apoptotic/necrotic cell damage. Treatment with rilpivirine reduced the levels of" exact="viral" post="RNA in the brain hippocampus and frontal cortex and"/>
 <result pre="with rilpivirine reduced the levels of viral RNA in the" exact="brain" post="hippocampus and frontal cortex and prevented apoptotic/necrotic cell damage,"/>
 <result pre="did not eliminate inflammation. These results indicate that rilpivirine suppressed" exact="viral" post="replication and disease development. However, it was notable that"/>
 <result pre="inflammation. These results indicate that rilpivirine suppressed viral replication and" exact="disease" post="development. However, it was notable that compound treatment did"/>
 <result pre="that compound treatment did not completely prevent weight loss or" exact="brain inflammation," post="suggesting that further improvement of potency may be required"/>
 <result pre="inÂ vivo potency of rilpivirine seems better than sofosbuvir, a" exact="hepatitis C" post="virus (HCV) nucleoside drug that was reported with anti-ZIKV"/>
 <result pre="from death, whereas sofosbuvir and other nucleoside inhibitors only conferred" exact="partial" post="protection.10 The study by Sariyer etÂ al.2 has provided"/>
 <result pre="EC90 value (a drug concentration required to inhibit 90% of" exact="viral" post="replication) may be readily advanced to clinical trials for"/>
 <result pre="tested in a pregnant mouse model for prevention of maternal-to-fetal" exact="viral" post="transmission.14 Collectively, the study by Sariyer etÂ al.2 reinforces"/>
 <result pre="report from the Global Virus NetworkAntiviral Res.144201722324628595824 2SariyerI.K.GordonJ.BurdoT.H.WolleboH.GiantiE.DonadoniM.BellizziA.CicaleseS.LoomisR.RobinsonJ.A.Suppression of Zika" exact="virus infection" post="in the brain by the antiretroviral drug rilpivirineMol. Ther.27201920672079this"/>
 <result pre="from the Global Virus NetworkAntiviral Res.144201722324628595824 2SariyerI.K.GordonJ.BurdoT.H.WolleboH.GiantiE.DonadoniM.BellizziA.CicaleseS.LoomisR.RobinsonJ.A.Suppression of Zika virus" exact="infection" post="in the brain by the antiretroviral drug rilpivirineMol. Ther.27201920672079this"/>
 <result pre="Virus NetworkAntiviral Res.144201722324628595824 2SariyerI.K.GordonJ.BurdoT.H.WolleboH.GiantiE.DonadoniM.BellizziA.CicaleseS.LoomisR.RobinsonJ.A.Suppression of Zika virus infection in the" exact="brain" post="by the antiretroviral drug rilpivirineMol. Ther.27201920672079this issue31653397 3ShanC.XieX.BarrettA.D.Garcia-BlancoM.A.TeshR.B.VasconcelosP.F.VasilakisN.WeaverS.C.ShiP.Y.Zika Virus:"/>
 <result pre="Virus InfectionCell Host Microbe20201625927027476412 5XuM.LeeE.M.WenZ.ChengY.HuangW.K.QianX.TcwJ.KouznetsovaJ.OgdenS.C.HammackC.Identification of small-molecule inhibitors of Zika" exact="virus infection" post="and induced neural cell death via a drug repurposing"/>
 <result pre="InfectionCell Host Microbe20201625927027476412 5XuM.LeeE.M.WenZ.ChengY.HuangW.K.QianX.TcwJ.KouznetsovaJ.OgdenS.C.HammackC.Identification of small-molecule inhibitors of Zika virus" exact="infection" post="and induced neural cell death via a drug repurposing"/>
 <result pre="via a drug repurposing screenNat. Med.2220161101110727571349 6TangH.HammackC.OgdenS.C.WenZ.QianX.LiY.YaoB.ShinJ.ZhangF.LeeE.M.Zika Virus Infects Human" exact="Cortical" post="Neural Progenitors and Attenuates Their GrowthCell Stem Cell18201658759026952870 7ZhuZ.GormanM.J.McKenzieL.D.ChaiJ.N.HubertC.G.PragerB.C.FernandezE.RichnerJ.M.ZhangR.ShanC.Zika"/>
 <result pre="Their GrowthCell Stem Cell18201658759026952870 7ZhuZ.GormanM.J.McKenzieL.D.ChaiJ.N.HubertC.G.PragerB.C.FernandezE.RichnerJ.M.ZhangR.ShanC.Zika virus has oncolytic activity against" exact="glioblastoma" post="stem cellsJ.Â Exp. Med.21420172843285728874392 8ChenQ.WuJ.YeQ.MaF.ZhuQ.WuY.ShanC.XieX.LiD.ZhanX.Treatment of Human Glioblastoma with"/>
 <result pre="and NNRTI-resistant HIV-1Antimicrob. Agents Chemother.54201071872719933797 13NobleC.G.LimS.P.AroraR.YokokawaF.NilarS.SehC.C.WrightS.K.BensonT.E.SmithP.W.ShiP.Y.A Conserved Pocket in the" exact="Dengue" post="Virus Polymerase Identified through Fragment-based ScreeningJ.Â Biol. Chem.29120168541854826872970 14RichnerJ.M.JaggerB.W.ShanC.FontesC.R.DowdK.A.CaoB.HimansuS.CaineE.A.NunesB.T.D.MedeirosD.B.A.Vaccine"/>
 <result pre="ScreeningJ.Â Biol. Chem.29120168541854826872970 14RichnerJ.M.JaggerB.W.ShanC.FontesC.R.DowdK.A.CaoB.HimansuS.CaineE.A.NunesB.T.D.MedeirosD.B.A.Vaccine mediated protection against Zika virus induced" exact="congenital" post="diseaseCell1702017273283.e1228708997 15DuanW.SongH.WangH.ChaiY.SuC.QiJ.ShiY.GaoG.F.The crystal structure of Zika virus NS5 reveals"/>
</results>
